A senior leader with over 30 years of extensive experience in viral immunology, spanning from foundational research to industry laboratories. Demonstrated success in steering vaccine development projects, overseeing large teams, and fostering collaboration with key stakeholders to execute impactful vaccine-related programs. Proven expertise in immunogenicity testing, method development, scale-up, method validation, project management, and revenue generation, coupled with a comprehensive understanding of regulatory compliance. Adept at strategic planning, financial management, and driving successful initiatives that advance public health outcomes on a global scale.
| ๐ Nationality | ๐บ๐ธ United States |
| ๐ก Residency | ๐บ๐ธ United States |
| ๐ Location | ๐บ๐ธ United States |
|
|
rok.co/@bailersverizonnet |
| ๐ Website | sdfljasfjkhsdfajsf โญ๏ธ Upgrade to Premium to contact |
|
|
sdfljasfjkhsdfajsf โญ๏ธ Upgrade to Premium to contact |
| Skilled in | method dev serology methods cell based methods team management recruitment mentoring budget projections revenue generation project director operations director quality systems external audits regulatory filings method validations data analysis |
| Fluent in | english |
| Preferred timezone | +5 |
| Last seen | 1 year ago |
| Signed up | 1 year ago |
| Badges |
๐จโ๐ป Remote worker ๐ Early adopter |
2019 - 2024: Senior Director @ Q2 Solutions
2002 - 2019: Director Immunogenicity Testing Program @ National Institutes of Health -Vaccine Research Center
1998 - 2002: Senior Scientist @ Merck
1987 - 1994: Ph.D. Viral Immunology @ Ohio State University
1979 - 1983: B.S. Microbiology @ Colorado State University